Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.
News & Analysis: GW Pharmaceuticals
Marijuana inhalables and edibles aren't the only things on the market anymore.
Cannabinoid-based medicines have made major advancements in research and uptake over the past few years.
The cannabis-based pharmaceutical company agreed to be acquired.
Will the total be greater than the sum of the parts?
The company's net loss was far narrower than many expected.
Few investors saw this one coming.
The deal to buy GW Pharmaceuticals creates a leader in neuroscience.
In a quiet market, marijuana companies stood out.
Investors cheered an unexpected acquisition of the cannabinoid-focused biotech.